Regulatory Milestone: The "Alternative Methods" Validation Race
The US Preclinical CRO Market dynamics in 2026 are heavily influenced by the FDA Modernization Act 2.0. While the law removed the animal testing mandate in late 2022, 2026 marks the first year where a significant number of "Non-Animal Only" safety packages have been successfully submitted for IND clearance. This has created a "Validation Race" among US CROs. To maintain competitive advantage,...
0 Commenti 0 condivisioni 45 Views 0 Anteprima
friendchat https://friendchat.fun